Pharmacists Warn Against Fake Weight-Loss Jabs Amid Ozempic Shortage

Shortages of the diabetes drug Ozempic, used off-label for weight loss, are expected to continue into next year, raising concerns over counterfeit products.

The National Pharmacy Association (NPA) cautions against buying unlicensed weight-loss injections online.
High demand and off-label prescribing contribute to the Ozempic shortage, impacting diabetic patients.
There is an increased risk of counterfeit Ozempic and Wegovy being sold online.
The NPA urges patients to consult their pharmacist or GP instead of purchasing medicines from unregulated sources.
Authorities are working to identify and prosecute those unlawfully trading in counterfeit medications.